Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2003
12/11/2003US20030228685 Bioartificial liver system
12/11/2003US20030228664 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2003US20030228662 Comprises nucleotide sequences coding tetrodoxin resistant transport protein for diagnosing, prevention and treatment of pain, muscular and cardiac disorders
12/11/2003US20030228660 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
12/11/2003US20030228658 Comprises nucleotide sequences coding membrane protein for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating melanomas, pigmentation disorders and inflammation; forensics; drug screening
12/11/2003US20030228656 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2003US20030228655 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2003US20030228653 Novel orphan cytokine receptor polypeptides
12/11/2003US20030228649 Polypeptides for identifying fungicidally active compounds
12/11/2003US20030228638 Isolating endothelial cells from whole blood and detecting human leukocte antigen specific antibody complexes for diagnosing organ rejection, blood, wound healing and vascular diseases
12/11/2003US20030228633 Compounds that activate the olfactory CNG channel will enhance smell and can be used to make foods more palatable for individuals with attenuated olfactory function
12/11/2003US20030228632 Stable RXR expressing cell line
12/11/2003US20030228606 Her-2 receptor tyrosine kinase molecules and uses thereof
12/11/2003US20030228601 Identifying nucleotide sequences capable of post-transcriptional gene silencing; regulatory sequences; transcriptional profiling; high throughput assays
12/11/2003US20030228576 Nucleotide sequence coding for a cleaving enzyme; can use in conjuction with substrate to produce toxins which impair abnormal cell growth; antitumor agents
12/11/2003US20030228329 Genetic engineering; insertion of gene; generating immunology response
12/11/2003US20030228319 Antitumor agents, anticancer agents
12/11/2003US20030228316 Mitochondrial creatine kinase antibody
12/11/2003US20030228308 Immunology active materials; complexing; anticancer agents
12/11/2003US20030228305 Compositions and methods for the diagnosis and treatment of tumor
12/11/2003US20030228303 Antibodies specific for native PrPsc
12/11/2003US20030228295 Use of human neural stem cells secreting GDNF for treatment of parkinson's and other neurodegenerative diseases
12/11/2003US20030228292 Methods of inducing or enhancing connective tissue repair
12/11/2003US20030228291 Polynucleotide that encodes a polypeptide; binding specificity; useful in bone marrow transplantation and gene therapy
12/11/2003US20030228290 Modular assembly of tissue engineered constructs
12/11/2003US20030228289 Universal chimera bank
12/11/2003US20030228287 Maintenance of islet cells
12/11/2003US20030228286 Therapy for degradation diseases; skin disorders; biodegradation matrix containing autologous cells; filling defects
12/11/2003US20030228282 Genetic engineered polypeptide; inserted into cell; blood disorders
12/11/2003US20030228258 Suicide tetramers and uses thereof
12/11/2003US20030226516 Polyvalent cation sensing receptor; animal growth regulator for fish
12/11/2003DE29824915U1 Sex-specific insemination of mammals with low number of sperm count
12/11/2003CA2492631A1 Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
12/11/2003CA2491420A1 Rb1 gene induced protein (rb1cc1) and gene
12/11/2003CA2488568A1 Methods of diagnosing and treating diabetes and insulin resistance
12/11/2003CA2488441A1 Synthetic antibody phage libraries
12/11/2003CA2488048A1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
12/11/2003CA2488013A1 Methods of using jnk or mkk inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes
12/11/2003CA2487939A1 Semaphorin-like proteins and methods of using same
12/11/2003CA2487926A1 Suicide tetramers comprising mhc class i and uses thereof
12/11/2003CA2487915A1 Allergen from mugwort pollen
12/11/2003CA2487897A1 Helper virus-free herpesvirus amplicon particles and uses thereof
12/11/2003CA2487895A1 Defensins: use as antiviral agents
12/11/2003CA2487765A1 Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment
12/11/2003CA2487724A1 Immunogenic sequences
12/11/2003CA2487410A1 Intramyocardial injection of autologous bone marrow
12/11/2003CA2487094A1 Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells
12/11/2003CA2487024A1 Control sequences of the human corin gene
12/11/2003CA2486616A1 Methods, compositions and kits for cell separation
12/11/2003CA2486548A1 Animal model for toxicology and dose prediction
12/11/2003CA2485939A1 Inducible eukaryotic expression system
12/11/2003CA2485862A1 Expansion and transdifferentiation of human acinar cells
12/11/2003CA2485653A1 Human 5-ht7 receptor promoter sequence
12/11/2003CA2485513A1 Modified phytases
12/11/2003CA2485203A1 Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants
12/11/2003CA2484629A1 Electrofusion of cells and apparatus therefore
12/11/2003CA2484627A1 Cell recovery
12/11/2003CA2483145A1 Transgenic plants with controlled distribution of a trait to progeny
12/11/2003CA2480326A1 Knockout mice and their use
12/10/2003EP1369484A1 Plant synthesizing copolyester from monomer derived from short-chain fatty acid and process for producing polyester
12/10/2003EP1369483A1 Allergen from mugwort pollen
12/10/2003EP1369481A1 Novel translational activity-promoting higher-order structure
12/10/2003EP1369430A2 Two human G-Protein coupled receptors: EBV-induced GPCR 2(EBI-2) and EBG-1-like GPCR
12/10/2003EP1368482A2 Nitrile hydratase and a method for producing amides
12/10/2003EP1368481A2 Characterization of the i-spoml endonuclease from fission yeast
12/10/2003EP1368477A1 Vaccine
12/10/2003EP1368474A1 Polynucleotide useful for modulating cancer cell proliferation
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368470A2 Transcriptional mediators of blood vessel development and endothelial differentiation
12/10/2003EP1368469A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
12/10/2003EP1368467A2 Putrescine-n-methyltransferase promoter
12/10/2003EP1368459A2 Influenza viruses with enhanced transcriptional and replicational capacities
12/10/2003EP1368458A2 Interferon-alpha induced gene
12/10/2003EP1368457A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells
12/10/2003EP1368456A2 Anti-bacterial vaccine compositions
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368367A1 Polynucleotide constructs for increased lysine production
12/10/2003EP1368061A2 Fusion cells and cytokine compositions for treatment of disease
12/10/2003EP1368052A2 Agents, which inhibit apoptosis in cells that are involved in wound healing
12/10/2003EP1368043A1 Blood brain barrier modulation using stressed autologous blood cells
12/10/2003EP1368036A1 Regulation of glucocorticoid concentration
12/10/2003EP1367982A2 Hair follicle neogenesis by injection of follicle progenitor cells
12/10/2003EP1367961A2 Peptide scaffold encapsulation of tissue cells and uses thereof
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP1367892A1 Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
12/10/2003EP1367886A2 Scce modified transgenic mammals and their use as models of human disease
12/10/2003EP1115432B1 Dermal scaffold using neutralized chitosan sponge or neutralized chitosan/collagen mixed sponge
12/10/2003EP0996726B1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
12/10/2003EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/10/2003EP0958371B1 Cytopathic viruses for therapy and prophylaxis of neoplasia
12/10/2003EP0912611B1 Human monoclonal antibodies to the hepatitis b surface antigen
12/10/2003EP0827532B1 Regeneration of both plant tissues and transgenic plant tissues using a new plant hormone, 5-bromoindole-3-acetic acid
12/10/2003EP0824589B1 Utrophin gene promoter
12/10/2003EP0724456B1 Antibodies to cd40
12/10/2003EP0680316B1 Novel parasitic helminth proteins
12/10/2003EP0679191B1 Detection and treatment of mutations in a cd40 ligand gene
12/10/2003EP0671920B1 An anti-idiotypic antibody and its use in diagnosis and in therapy in hiv-related disease
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003EP0502892B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
12/10/2003CN1461345A Process for increasing crop yield or biomass using protoporphyrinogen oxidase gene
1 ... 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 ... 1827